Intellectual property law

Forward Pharma Announces the Decision of the Technical Board of Appeal of the European Patent Office in the EP2801355 Appeal Hearing

Retrieved on: 
Lundi, septembre 6, 2021

COPENHAGEN, Denmark, Sept. 06, 2021 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (we, Forward or the Company), today announced that the Technical Board of Appeal (the TBA) of the European Patent Office (the EPO) has dismissed Forwards appeal of the previous decision of the EPO Opposition Division to revoke the EP2801355 patent (the 355 patent) following the oral hearing.

Key Points: 
  • COPENHAGEN, Denmark, Sept. 06, 2021 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (we, Forward or the Company), today announced that the Technical Board of Appeal (the TBA) of the European Patent Office (the EPO) has dismissed Forwards appeal of the previous decision of the EPO Opposition Division to revoke the EP2801355 patent (the 355 patent) following the oral hearing.
  • The TBA made its decision after considering Forwards appeal against the decision of the Opposition Division and third-party submissions from several opponents.
  • The TBA will issue detailed reasons for the decision in written form in due course, and following receipt and review of these, Forward will announce future plans for the Company.
  • The denial of a petition for review would end the Opposition Proceeding in favor of the opponents.

CARDIOGENICS HOLDINGS INC. ANNOUNCES LICENSE AGREEMENT AND DIVIDEND DISTRIBUTION

Retrieved on: 
Vendredi, septembre 3, 2021

Caledon, Ontario, Sept. 03, 2021 (GLOBE NEWSWIRE) -- CardioGenics Holdings Inc. (OTC PINK: CGNH) (theCompany)announced todaythat its subsidiary, CardioGenics Inc. (CardioGenics), has entered into a license agreement with Covidgenics Corp., a private company located in Ontario, which grants to Covidgenics an exclusive 10-year global license of the Companys proprietary technology for its QL Care Analyzer and paramagnetic beads.

Key Points: 
  • Caledon, Ontario, Sept. 03, 2021 (GLOBE NEWSWIRE) -- CardioGenics Holdings Inc. (OTC PINK: CGNH) (theCompany)announced todaythat its subsidiary, CardioGenics Inc. (CardioGenics), has entered into a license agreement with Covidgenics Corp., a private company located in Ontario, which grants to Covidgenics an exclusive 10-year global license of the Companys proprietary technology for its QL Care Analyzer and paramagnetic beads.
  • In order to provide the Companys shareholders an opportunity to participate directly in any increased value that may develop from Covidgenics further development efforts, the Company intends to issue to its shareholders, as a dividend, the Covidgenicsshares received by CardioGenics under the license agreement, subject to compliance with all applicable laws.
  • CardioGenics Holdings intends to deliver the Covidgenics shares to its shareholders on a pro rata basis according to their holdings as of a record date of September 13, 2021.
  • The shares distributed to CardioGenics Holdings shareholders will be held, in the shareholder name, at Covidgenics.

Evolv Technology to Release Second Quarter Financial Results on August 16, 2021

Retrieved on: 
Mercredi, août 4, 2021

Evolv Technology (NASDAQ: EVLV), the global leader in weapons detection security screening, today announced that it will release financial results for the second quarter ended June 30, 2021 on Monday, August 16, 2021, after the market closes.

Key Points: 
  • Evolv Technology (NASDAQ: EVLV), the global leader in weapons detection security screening, today announced that it will release financial results for the second quarter ended June 30, 2021 on Monday, August 16, 2021, after the market closes.
  • The conference call may be accessed in the United States by dialing +1.844.867.6169 and using access code EVLV.
  • Evolv Technology (NASDAQ: EVLV) is the leader in SaaS-based weapons detection for security screening.
  • Evolv Technology, Evolv Express, Evolv Insights, and Evolv Cortex AI are registered trademarks or trademarks of Evolv Technologies, Inc. in the United States and other jurisdictions.

GBT Filed a Nonprovisional Patent Application - IC Layout Design Rule Automatic Correction

Retrieved on: 
Mercredi, août 4, 2021

SAN DIEGO, Aug. 04, 2021 (GLOBE NEWSWIRE) -- GBT Technologies Inc. ( OTC PINK:GTCH ) ("GBT or the Company), filed a nonprovisional patent application for ICs automatic design rule correction system and method; application #17391292 with the U.S. Patent and Trademark Office (USPTO).

Key Points: 
  • SAN DIEGO, Aug. 04, 2021 (GLOBE NEWSWIRE) -- GBT Technologies Inc. ( OTC PINK:GTCH ) ("GBT or the Company), filed a nonprovisional patent application for ICs automatic design rule correction system and method; application #17391292 with the U.S. Patent and Trademark Office (USPTO).
  • The patent protects systems and methods for automatic correction of geometrical design rule violations which typically takes vast amount of time to correct manually.
  • A typical process of manual correction of design rule violations may take several hours or even days, per layout block; and significantly, increases the overall design time.
  • IC design firms will benefit designing smaller chips, faster and much cheaper, which will create many new markets and opportunities.

Executives from Macy's, Microsoft, Funko, and Xbox Confirmed to Address the Future of Licensing and Retail at Brand & Licensing Innovation Summit North America

Retrieved on: 
Mercredi, août 4, 2021

Featuring expert-led sessions spanning a breadth of topics, B&LIS North America is strategically designed to be a one-stop-shop for in-depth education and trend analysis.

Key Points: 
  • Featuring expert-led sessions spanning a breadth of topics, B&LIS North America is strategically designed to be a one-stop-shop for in-depth education and trend analysis.
  • The Brand & Licensing Innovation Summit (B&LIS) is an event series that brings annual conferences focused on the brand licensing industry to the two largest licensing markets globally, North America and Europe.
  • The summits are designed to complement the Global Licensing Group's trade shows and information products, which include Licensing Expo, Brand Licensing Europe, Licensing Expo Japan, Licensing Expo Shanghai, and License Global magazine.
  • The following events and information products are produced for the licensing industry by the Global Licensing Group at Informa Markets: Licensing Expo, Brand & Licensing Innovation Summits, Brand Licensing Europe, Licensing Expo Japan, Licensing Expo Shanghai, License Global magazine, License Global Daily E-News, and The Licensing Mixtape podcast.

Fake clothes and luxury items worth € 16.5 million seized in Spain

Retrieved on: 
Mardi, août 3, 2021

The action day on 21 July 2021 led to:

Key Points: 
  • The action day on 21 July 2021 led to:

    The investigation was triggered in 2019 by a statement from an association of brand representatives.

  • They reported the sale of counterfeit goods in the Spanish towns of La Jonquera and Els Lmits, close to the French-Spanish border.
  • Overall, the clothes, leather accessories and shoes seized during the action day are estimated to be worth 16.5 million.
  • Europols Intellectual Property Crime Coordinated Coalition (IPC3) is co-funded by EUIPO (European Union Intellectual Property Office) to combat intellectual property crime.

Access Copyright v. York University: Supreme Court Decision Preserves Quebec Model of Collective Management

Retrieved on: 
Vendredi, juillet 30, 2021

MONTREAL, July 30, 2021 (GLOBE NEWSWIRE) -- The Supreme Court of Canada has issued an important decision in the dispute between the collective society Access Copyright and York University.

Key Points: 
  • MONTREAL, July 30, 2021 (GLOBE NEWSWIRE) -- The Supreme Court of Canada has issued an important decision in the dispute between the collective society Access Copyright and York University.
  • By refusing to declare York University's copyright policies to be fair dealing, the Court has allowed the book industry to preserve its collective management model and is allowing Copibec to continue to pay some $12.5 million annually to authors and publishers.
  • It is the Quebec counterpart to the Copyright Clearance Center (United States), the Centre Franais d'Exploitation du Droit de Copie (France) and Access Copyright (Canada outside Quebec).
  • The professional union has been working since 1977 to defend the socio-economic rights of writers and to promote Quebec literature in Quebec, Canada and abroad.

TVNET /WRLD1 Announces launch of NFT1X as a TV Network NFT information resource and global community further linked to an NFT Digital Assets Exchange

Retrieved on: 
Samedi, juillet 31, 2021

SAN FRANCISCO, July 31, 2021 /PRNewswire/ --Nathan Sassover, CEO of TVNET/WRLD1 today announced the launch of NFT1X as a TV network formatted NFT information resource/social channel further linked to an NFT Digital Assets Exchange for Digital Media collections inclusive of the underlying IP-Intellectual Property of those assets fully owned by TVNET/WRLD1 and its affiliates.

Key Points: 
  • SAN FRANCISCO, July 31, 2021 /PRNewswire/ --Nathan Sassover, CEO of TVNET/WRLD1 today announced the launch of NFT1X as a TV network formatted NFT information resource/social channel further linked to an NFT Digital Assets Exchange for Digital Media collections inclusive of the underlying IP-Intellectual Property of those assets fully owned by TVNET/WRLD1 and its affiliates.
  • These IP elements include domain name and web site ownership, copyrights and trademarks or pending trademarks [where applicable].
  • Sassover stated: " The NFT category of crypto has been dominated by a first wave comprised of high-profile artists and sports fandom.
  • NFT1X is more narrowly focused on a hybrid model conjoining a primary Marketplace for its large and extensive range of alternative Digital Assets originating as video collections /classic TV Series extending to geo centric TV networks across the 8 regions of the world.

Appendix 4C Quarterly Activity Report

Retrieved on: 
Vendredi, juillet 30, 2021

Total Operating Activities resulted in net cash usage of US$20.7 million in the quarter ended June 30, 2021.

Key Points: 
  • Total Operating Activities resulted in net cash usage of US$20.7 million in the quarter ended June 30, 2021.
  • This included an investment of US$10.8 million associated with remestemcel-L for SR-aGVHD and COVID-19 ARDS.
  • Specifically:
    Revenues from TEMCELL royalties for the quarter ended June 30, 2021 were US$1.9 million compared to US$0.7 million in the quarter ended June 30, 2020.
  • The DSMB recommended that the trial complete with the enrolled 222 patients, and that all be followed-up as planned.

Xtant Medical to Issue Second Quarter 2021 Financial Results on August 5, 2021

Retrieved on: 
Jeudi, juillet 29, 2021

Xtant Medical Holdings, Inc. ( www.xtantmedical.com ) is a global medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures.

Key Points: 
  • Xtant Medical Holdings, Inc. ( www.xtantmedical.com ) is a global medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures.
  • Xtant people are dedicated and talented, operating with the highest integrity to serve our customers.
  • The symbols and denote trademarks and registered trademarks of Xtant Medical Holdings, Inc. or its affiliates, registered as indicated in the United States, and in other countries.
  • All other trademarks and trade names referred to in this release are the property of their respective owners.